WASHINGTON, D.C.—A majority (70 percent) of elderly dementia patients prescribed dementia drugs are on them long-term despite the lack of evidence that they provide any benefit beyond one year, according to a new report by AARP Public Policy Institute. The study found that some patients took dementia drugs for as long as a decade, costing as much as $20,000 per patient.

WASHINGTON, D.C.—Today AARP CEO Jo Ann Jenkins released a statement in reaction to the news of music legend Aretha Franklin’s passing.

WASHINGTON, DC—On June 25, AARP announced an unprecedented investment of $60 million in the Dementia Discovery Fund (DDF) the first and largest venture fund focused on discovering and developing effective new drugs for treating dementia and ultimately a cure. Now, a special report in the July/August issue of AARP Bulletin details the scope of this healthcare issue, provides a profile of DDF, and explains why research to date has yielded so few solutions, despite tens of billions of dollars being spent.

WASHINGTON, D.C. — AARP announced today the launch of “An AARP Take on Today,” a weekly podcast hosted by Bob Edwards, the original and longtime host of NPR’s flagship program “Morning Edition.” Each new episode will feature in-depth news interviews on timely topics with guest experts on health, work, money, aging, entertainment and more.

WASHINGTON, DC—With nearly 10 million new cases of dementia and Alzheimer’s disease occurring each year1, and no cure, today AARP launched a new campaign, “Disrupt Dementia.” The campaign...